Beovu

Medicinal product

(Invented) name

Beovu

Active substance (s)

Brolucizumabas

Strength

120 mg/ml

Pharmaceutical form

injekcinis tirpalas užpildytame švirkšte

Route (s) of administration

vartoti į stiklakūnį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

S01LA06, brolucizumab

Marketing authorisation holder

Novartis Europharm Ltd., Airija

Date of authorisation

2020-02-13

Date of renewal

Documents

Beovu mokomoji medziaga pacientams.pdf

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection in pre-filled syringe	1 ml
Brolucizumabas	120 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
103322	89424	1089424	užpildytas švirkštas	0,165 ml N1		Receptinis	EU/1/19/1417/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2020-02-13	Registruotas